BRAIN.Q · raw details

Restorative Brain Health Therapeutics to Reverse Disability After Neurological Disease · Jerusalem · Founded 2016

active Series B ← back to profile

Highlights

IIA supported (ever)1 patentProfile claimed by owner

About

Restorative Brain Health Therapeutics to Reverse Disability After Neurological Disease

BRAIN.Q is redefining the future of neurological recovery, with a mission to transform lives through innovative, noninvasive therapies. The company utilizes advanced AI-powered technology to develop network-targeting electromagnetic precision therapy, designed to enhance and accelerate brain recovery following ischemic stroke—the leading cause of disability worldwide. Delivered through a cloud-based platform, the therapy is seamlessly adaptable for both hospital and home settings.

Celebrated as a pioneer in neurological innovation, BRAIN.Q has earned CE Mark approval, the FDA’s Breakthrough Device Designation, and the esteemed recognition of the European Innovation Council.

Building on these advancements, BRAIN.Q is actively progressing its pivotal EMAGINE II study in the U.S., aiming to secure FDA clearance for its Q Therapeutic System and expand its transformative impact on patient recovery.

Guided by a world-class leadership team and a bold vision for the future of neurological recovery, BRAIN.Q is driven by its mission to restore brain health and dignity to stroke survivors, empowering them to regain independence.

Identity

NameBRAIN.Q
Slugbrain-q
Type / kindstartup
Crunchbase IDbrainq
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN69u_sIDA

Status

Statusactive
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtJerusalem District
HQ cityJerusalem
HQ addressGivat Ram, Jerusalem, Israel

Web & social

Websitehttps://brainqtech.com
LinkedInhttps://www.linkedin.com/company/5549321
Twitter / Xhttps://twitter.com/brainqtech
Facebookhttps://www.facebook.com/BrainQTech
YouTubehttps://www.youtube.com/@BrainQTech

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Therapeutics
Technologies
Artificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business models
B2B2CB2B
Tags
non-invasivestrokedegenerative-diseasesmedical-devicesneurologyrehabilitationartificial-intelligencemachine-learningdigital-healthcareclinicshospitalsmedical-technologiesneurosciencedigital-therapeuticspatientswearablemhealth

Funding

Total raised$52.4M
Current stageSeries B

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}